Drug Shortage Report for PONSTAN
Report ID | 20789 |
Drug Identification Number | 00155225 |
Brand name | PONSTAN |
Common or Proper name | Ponstan |
Company Name | AA PHARMA INC |
Market Status | DORMANT |
Active Ingredient(s) | MEFENAMIC ACID |
Strength(s) | 250MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL |
Packaging size | 100 BTL |
ATC code | M01AG |
ATC description | ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2017-09-01 |
Estimated end date | |
Actual end date | 2020-07-28 |
Shortage status | Resolved |
Updated date | 2020-07-29 |
Company comments | Product has been discontinued |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1165 CREDITSTONE ROAD VAUGHAN, ONTARIO CANADA L4K 4N7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2017-09-01 | English | Compare |
v2 | 2017-09-01 | French | Compare |
v3 | 2017-09-02 | English | Compare |
v4 | 2018-05-24 | English | Compare |
v5 | 2018-05-24 | French | Compare |
v6 | 2020-07-28 | English | Compare |
v7 | 2020-07-28 | French | Compare |
v8 | 2020-07-29 | English | Compare |
Showing 1 to 8 of 8